CR10727A - Quelatos metalicos con radical peg perfluorado, metodo para su fabricacion y su uso - Google Patents

Quelatos metalicos con radical peg perfluorado, metodo para su fabricacion y su uso

Info

Publication number
CR10727A
CR10727A CR10727A CR10727A CR10727A CR 10727 A CR10727 A CR 10727A CR 10727 A CR10727 A CR 10727A CR 10727 A CR10727 A CR 10727A CR 10727 A CR10727 A CR 10727A
Authority
CR
Costa Rica
Prior art keywords
perfluorated
metal chelates
manufacturing
radical
peg
Prior art date
Application number
CR10727A
Other languages
English (en)
Inventor
Heiko Schirmer
Hanns-Joachim Weinmann
Johannes Platzek
Ludwig Zorn
Bernd Misselwitz
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR10727A publication Critical patent/CR10727A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invencion se relaciona con los objetos caracterizados en las reivindicaciones, especificamente con quelatos metalicos con radical PEG perfluorado, con metodos para su preparacion y con uso para diagnostico NMR y por rayos X, radiodiagnostico y radioterapia y para linfografia MRT.
CR10727A 2006-10-18 2009-04-17 Quelatos metalicos con radical peg perfluorado, metodo para su fabricacion y su uso CR10727A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006049821A DE102006049821A1 (de) 2006-10-18 2006-10-18 Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
US85296306P 2006-10-20 2006-10-20
US89007107P 2007-02-15 2007-02-15

Publications (1)

Publication Number Publication Date
CR10727A true CR10727A (es) 2009-07-23

Family

ID=38670854

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10727A CR10727A (es) 2006-10-18 2009-04-17 Quelatos metalicos con radical peg perfluorado, metodo para su fabricacion y su uso

Country Status (21)

Country Link
US (1) US8263040B2 (es)
EP (1) EP2089362A1 (es)
JP (1) JP5475454B2 (es)
KR (1) KR101451446B1 (es)
CN (1) CN101687803B (es)
AU (1) AU2007312691A1 (es)
BR (1) BRPI0717466A2 (es)
CA (1) CA2666910C (es)
CO (1) CO6170342A2 (es)
CR (1) CR10727A (es)
CU (1) CU23837B1 (es)
DE (1) DE102006049821A1 (es)
GT (1) GT200900087A (es)
IL (1) IL198173A0 (es)
MX (1) MX2009004097A (es)
MY (1) MY148553A (es)
NO (1) NO20091912L (es)
NZ (1) NZ576249A (es)
RU (1) RU2470014C2 (es)
SG (1) SG177994A1 (es)
WO (1) WO2008046463A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009021948A1 (en) * 2007-08-13 2009-02-19 Ge Healthcare As Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
US11529309B2 (en) * 2016-04-29 2022-12-20 University Of Houston System Compositions, methods and kits for treating a contact lens
CN111138652B (zh) * 2018-05-16 2022-11-04 广州优尔材料科技有限公司 含全氟聚醚基的硅烷化合物、其制备方法、表面处理剂及物品
WO2020203671A1 (ja) * 2019-03-29 2020-10-08 ダイキン工業株式会社 フルオロポリエーテル基含有化合物
WO2025058000A1 (ja) 2023-09-13 2025-03-20 東レ株式会社 癌の治療、予防及び／又は診断用医薬組成物

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588279A (en) * 1982-10-27 1986-05-13 Konishiroku Photo Industry Co., Ltd. Cleaning roller intermediate transfer member
US4586511A (en) * 1983-03-04 1986-05-06 Children's Hospital Medical Center Methods and compositions for detecting and imaging a gas in an animal by nuclear magnetic resonance
US4639364A (en) * 1984-11-14 1987-01-27 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
EP0292306A3 (en) 1987-05-20 1989-09-13 Nippon Shokubai Co., Ltd. Methylolaminotriazine condensates and method for production thereof
US4838274A (en) 1987-09-18 1989-06-13 Air Products And Chemicals, Inc. Perfluoro-crown ethers in fluorine magnetic resonance imaging
US5114703A (en) 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
DE4008179A1 (de) * 1990-03-12 1991-09-19 Schering Ag Fluorbenzolsulfonamide
US5250283A (en) 1990-03-28 1993-10-05 Molecular Biosystems, Inc. Organic contrast agent analog and method of making same
US5318770A (en) 1991-10-25 1994-06-07 Mallinckrodt Medical, Inc. Trifluoromethyl analogs of X-ray contrast media for magnetic resonance imaging
DE4203254C2 (de) 1992-02-05 1996-05-02 Max Planck Gesellschaft Fluorhaltige Markierungsverbindung für NMR-Untersuchungen und deren Verwendung
US5482650A (en) * 1992-04-28 1996-01-09 Minnesota Mining And Manufacturing Company Liquid crystal compounds having perfluoroether terminal portions
US5756688A (en) * 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5401493A (en) 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
JPH0797340A (ja) 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
US5502094A (en) 1994-05-20 1996-03-26 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
US5702637A (en) * 1995-04-19 1997-12-30 Minnesota Mining And Manufacturing Company Liquid crystal compounds having a chiral fluorinated terminal portion
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744003B4 (de) 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
DE19744004C1 (de) 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
US6495118B1 (en) * 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
WO1999017809A2 (en) 1997-10-02 1999-04-15 Epix Medical, Inc. Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
DE19914101C1 (de) 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6461587B1 (en) * 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US6939329B1 (en) * 1999-10-08 2005-09-06 Harvest Technologies Corporation Apparatus for holding and operating one or more syringes
DE10066210B4 (de) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
DE10040858C2 (de) 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
US6676928B2 (en) * 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
DE10040381C1 (de) * 2000-08-11 2002-06-06 Schering Ag Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
US6641797B2 (en) * 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
RU2206605C1 (ru) * 2002-03-18 2003-06-20 Здоров Юрий Павлович Противоизносная присадка к смазочным средам и топливу
JP2005531647A (ja) * 2002-04-11 2005-10-20 カルボマー インク 新規なイメージングプローブ
US7344704B2 (en) * 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
JP2004101881A (ja) * 2002-09-10 2004-04-02 Konica Minolta Holdings Inc ドライイメージング材料
WO2005072780A2 (en) * 2004-01-16 2005-08-11 Carnegie Mellon University Cellular labeling for nuclear magnetic resonance techniques
RU2296756C2 (ru) * 2005-05-17 2007-04-10 Федеральное унитарное государственное предприятие "Государственный научно-исследовательский институт биологического приборостроения" (ГосНИИ БП) Комплексообразующие дибензосодержащие пятичленные циклические соединения, содержащие два симметричных бета-дикарбонильных заместителя с фторированными радикалами

Also Published As

Publication number Publication date
MX2009004097A (es) 2009-07-10
CN101687803A (zh) 2010-03-31
SG177994A1 (en) 2012-02-28
NZ576249A (en) 2012-03-30
NO20091912L (no) 2009-07-17
CO6170342A2 (es) 2010-06-18
GT200900087A (es) 2010-04-19
MY148553A (en) 2013-04-30
IL198173A0 (en) 2009-12-24
HK1141526A1 (en) 2010-11-12
US8263040B2 (en) 2012-09-11
BRPI0717466A2 (pt) 2014-04-15
RU2009118486A (ru) 2010-11-27
AU2007312691A1 (en) 2008-04-24
CN101687803B (zh) 2012-05-30
KR20090082222A (ko) 2009-07-29
JP2010506862A (ja) 2010-03-04
CU20090059A7 (es) 2011-03-21
CA2666910C (en) 2013-12-24
US20080159954A1 (en) 2008-07-03
WO2008046463A1 (de) 2008-04-24
EP2089362A1 (de) 2009-08-19
KR101451446B1 (ko) 2014-10-16
JP5475454B2 (ja) 2014-04-16
CA2666910A1 (en) 2008-04-24
RU2470014C2 (ru) 2012-12-20
DE102006049821A1 (de) 2008-04-24
CU23837B1 (es) 2012-10-15

Similar Documents

Publication Publication Date Title
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
MX2012009088A (es) Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos.
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
PL2371385T3 (pl) Zastosowanie kompozycji immunogennej do zmniejszania objawów klinicznych u świń
CY2019042I1 (el) Οφθαλμολογικες συνθεσεις και η χρηση τους
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
TW200719913A (en) Anti-madcam antibody compositions
MX353352B (es) Anticuerpos anti-cd100 y metodos para su uso.
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
UY29376A1 (es) Anilidas de ácido pirazolcarboxílico, un procedimiento para su obtencón y productos que contienen las mismas para combatir hongos nocivos.
UY33124A (es) Agentes y epítopos enlazados a wise
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
DK1858488T3 (da) Tigecyclinsammensætninger samt fremstillingsfremgangsmåder
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
BR112014008089A2 (pt) método para diagnosticar o mal de alzheimer, uso do método, e, kit para a realização do método
MX2012007041A (es) Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri).
DK3461871T3 (da) Sammensætninger omfattende trans hfc-1234ze og hfc-1234yf
CR10727A (es) Quelatos metalicos con radical peg perfluorado, metodo para su fabricacion y su uso
ECSP088743A (es) Anticuerpos para egfl7 y métodos para su uso
IT1395917B1 (it) Apparecchiatura e metodo per la lucidatura delle cavita' di componenti meccanici.
CR9645A (es) Complejos con contenido de perfluoroalquilo, procedimientos para su preparacion asi como su uso
BRPI0922908A2 (pt) "composição compreendendo pelo menos dois cicloalquilmeticonas diferentes e uso deste".
ES2534911T3 (es) Uso de plasmina para el tratamiento de fallo de filtración después de trabeculectomía
DOP2006000166A (es) Complejos metálicos con contenido de perfluroalquilo, procedimientos para su preparación, así como su uso

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)